HC Wainwright & Co. Reiterates Buy on Connect Biopharma Hldgs, Maintains $7 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 86.2%

Neg 0% Neu 86.2% Pos 0%

HC Wainwright & Co. analyst Brandon Folkes reiterates Connect Biopharma Hldgs (NASDAQ:CNTB) with a Buy and maintains $7 price target.